---
figid: PMC6961090__LI-37-77-g001
figtitle: Epidermal growth factor receptor pathway and mechanism of action of osimertinib
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC6961090
filename: LI-37-77-g001.jpg
figlink: pmc/articles/PMC6961090/figure/F1/
number: F1
caption: Epidermal growth factor receptor pathway and mechanism of action of osimertinib
papertitle: 'Osimertinib as an emerging therapeutic modality in nonsmall cell lung
  cancer: Opportunities and challenges in Indian scenario.'
reftext: Sayanta Thakur, et al. Lung India. 2020 Jan-Feb;37(1):77-78.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9280778
figid_alias: PMC6961090__F1
figtype: Figure
redirect_from: /figures/PMC6961090__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6961090__LI-37-77-g001.html
  '@type': Dataset
  description: Epidermal growth factor receptor pathway and mechanism of action of
    osimertinib
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TGFA
  - EGF
  - TK1
  - TK2
  - KRAS
  - HRAS
  - NRAS
  - JAK1
  - JAK2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - EPHB2
  - MAPK1
  - MAPK3
  - BCL2L11
  - STAT3
  - NFKB1
  - MTOR
  - Osimertinib
---
